Review



rabbit anti cd42b  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech rabbit anti cd42b
    Rabbit Anti Cd42b, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cd42b/product/Proteintech
    Average 93 stars, based on 16 article reviews
    rabbit anti cd42b - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Proteintech rabbit anti cd42b
    Rabbit Anti Cd42b, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cd42b/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti cd42b - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Proteintech rabbit anti-cd42b polyclonal antibody
    Rabbit Anti Cd42b Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-cd42b polyclonal antibody/product/Proteintech
    Average 90 stars, based on 1 article reviews
    rabbit anti-cd42b polyclonal antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-cd42b
    Rabbit Anti Cd42b, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-cd42b/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit anti-cd42b - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal anti cd42 ab
    Rabbit Polyclonal Anti Cd42 Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti cd42 ab/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti cd42 ab - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti cd42b antibody
    Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, <t>CD42b</t> (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.
    Rabbit Anti Cd42b Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cd42b antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti cd42b antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc rabbit anti cd42b
    Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, <t>CD42b</t> (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.
    Rabbit Anti Cd42b, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cd42b/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    rabbit anti cd42b - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology rabbit anti human cd42b
    Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, <t>CD42b</t> (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.
    Rabbit Anti Human Cd42b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human cd42b/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    rabbit anti human cd42b - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit anti-human cd42b sc-292722
    Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, <t>CD42b</t> (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.
    Rabbit Anti Human Cd42b Sc 292722, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human cd42b sc-292722/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit anti-human cd42b sc-292722 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, CD42b (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.

    Journal: Cancer Research

    Article Title: Megakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis

    doi: 10.1158/0008-5472.can-21-1180

    Figure Lengend Snippet: Figure 2. Hyperglycemia boosts platelet activation and clearance invivo. A, Platelets from control or hyperglycemic mice were stimulated with ADP, AA, thrombin, or collagen. Quantifications of the percentages of CD62pþ platelets upon the indicated treatments (n ¼ 6 samples per group). B, Representative aggregometry tracings of platelet-rich plasma in response to ADP in control or hyperglycemic groups. The hyperglycemic group showed increased aggregation (n ¼ 3 samples per group). C, Representative clot retraction micrographs of platelet-rich plasma in response to collagen agonist in control or hyperglycemic groups. Quantifications of the clot retraction analysis (n ¼ 6 samples per group). D, PLT, PDW, MPV, PCT analysis in whole blood from control or hyperglycemic groups (n ¼ 6 samples per group). E and F, Occlusion of mesenteric arterioles upon FeCl3-induced injury of the endothelial barrier. Representative thrombi micrographs upon FeCl3- induced mesenteric arteriole injury with platelets from control or hyperglycemic groups. Quantifications of FeCl3-induced mesenteric arteriole thrombosis (n ¼ 6 samples per group). G, CD42b (green) and F4/80 (red) immunofluorescent staining micrographs of the spleen in control or hyperglycemic mice. Quantifications of CD42bþ area (n ¼ 6 random fields per group). Scale bar in top panels, 100 mm. Scale bar in bottom panels, 50 mm. H, Sham operation or splenectomy was performed and mice were then transferred to hyperglycemia modeling for 7 days. Peripheral blood samples were collected for whole blood analysis. Quantifications of PLT in the indicated groups (n ¼ 6 samples per group). , P < 0.05; , P < 0.01; , P < 0.001; n.s., not significant. Data presented as mean SEM.

    Article Snippet: For immunofluorescence staining, paraffin-embedded tissue sections or cells on glass coverslips were stained with a rabbit anti-CD42b antibody (catalog no. 12860-1-AP, Proteintech; RRID:AB_10644481; 1:50); a rabbit anti-GRP75 antibody (catalog no. 3593S, Cell Signaling Technology; RRID:AB_2120328; 1:100), and a rabbit anti-SLC2A1 antibody (catalog no. A11170, ABclonal; RRID:AB_2758445; 1:100).

    Techniques: Activation Assay, Control, Clinical Proteomics, Staining